Pharma Clinical Trials
NICaS Can Help You To:
- Assess inclusion criteria
- Obtain real-time dose titration information
- Monitor cardiac safety in both cardiovascular and non-cardiovascular trials
- Evaluate drug efficacy and safety
- Support single- or multi-site clinical trials
- Document desired and adverse effects of candidate compounds
- Reduce total trial time by facilitating patient recruitment
- Decrease time-to-market of successful compounds
NICaS unique technology:
Allows easy application with only two sensors
Secures the data transfer to the core lab
Accurately assesses the smallest hemodynamic changes
- Paredes OL, Shite J, Shinke T, et al. Impedance cardiography for cardiac output estimation: reliability of wrist-to-ankle electrode configuration. Circ J. 2006;70(9):1164-1168. doi:10.1253/circj.70.1164
- Cotter G, Schachner A, Sasson L, Dekel H, Moshkovitz Y. Impedance cardiography revisited. Physiol Meas. 2006;27(9):817-827. doi:10.1088/0967-3334/27/9/005
- Cotter G, Moshkovitz Y, Kaluski E, et al. Accurate, noninvasive continuous monitoring of cardiac output by whole-body electrical bioimpedance. Chest. 2004;125(4):1431-1440. doi:10.1378/chest.125.4.1431
- Tita C, Gilbert EM, Van Bakel AB, et al. A Phase 2a dose-escalation study of the safety, tolerability, pharmacokinetics, and haemodynamic effects of BMS-986231 in hospitalized patients with heart failure with reduced ejection fraction. Eur J Heart Fail. 2017;19(10):1321-1332. doi:10.1002/ejhf.897
Related Clinical Markets
Related Clinical Studies
Pharmacologic treatment of hypertension guided by non-invasive haemodynamics in primary care improves blood pressure control
Authors:Â D Romer, J Cleland, P Sobotka, R Matthews, R Kaiser, I Granov, J Froehlich, M Perez, F Colangelo, R Crossey, M Bottorff, C Hardtke,
Hypertensive vs. normotensive blood pressure response to advanced conduction disorders: comparison of baseline non-invasive haemodynamic evaluation
Authors:Â Katia Orvin, Shelly Vons, Alon Barsheshet, Ciel Zehavi, Gregory Golovchiner, Georgy Rusadze, Ori Rahat, Ran Kornowski, Tsahi T Lerman, Aharon Erez Conclusions: Haemodynamic presentations
Whole-Body Impedance Cardiography-Derived Haemodynamic Parameters Associated With Outcomes in Clinically Stable Heart Failure Patients With Reduced Ejection Fraction
Authors:Â Emelissa J Valcourt; Olivia Pieroni; Karen E Alvarez;Â Mohammad Zahurul Islam; Hilary Bews; Aleksander Dokollari; Anita Soni;Â Shelley Zieroth; Ashish H Shah Conclusions:Â Non-invasively obtained resting SI
Acute Hemodynamic Changes Induced by Cardiac Contractility Modulation Evaluated Using the NICaS® System: A Pilot Study
Authors:Â Andrea Madeo, Silvana De Bonis, Anna Lucia Cavaliere, Giovanni Bisignani Heart failure (HF) with reduced ejection fraction remains a significant global health challenge despite
Utility of NICaS Non-Invasive Hemodynamic Monitoring in Critically Ill Patients with COVID-19
Authors: Wisam Zabeeda, Jonah Benjamin Cohen, Anat Reiner Benaim, Shiri Zarour, Yael Lichter, Idit Matot, Or Goren Conclusion: Non-invasive hemodynamic monitoring via the NICaS device
The Impact of Positive Inotropic Therapy on Hemodynamics and Organ Function in Acute Heart Failure: A Differentiated View
Authors: Juan Cheko, Nikolaos Patsalis, Julian Kreutz, Dimitar Divchev, Georgios Chatzis, Bernhard Schieffer, Birgit Markus Conclusion: Patients with acute decompensated HF benefit from positive inotropic
Contact Us
